Form 4: Elevance Health CEO Gail Boudreaux Increases Stake with Significant Stock Purchase

Elevance Health's President and CEO, Gail Boudreaux, acquired 8,500 shares of common stock through multiple open market purchases on July 18, 2025, signaling strong insider confidence.

Summary

• Gail Boudreaux, President and CEO of Elevance Health, Inc. (ELV), purchased a total of 8,500 shares of the company's common stock on July 18, 2025.
• The purchases were executed in three separate transactions at weighted average prices:
• 2,334 shares at $286.07 per share (ranging from $285.50 to $286.43).
• 5,116 shares at $287.12 per share (ranging from $286.70 to $287.69).
• 1,050 shares at $287.96 per share (ranging from $287.72 to $288.14).
• Following these transactions, Gail Boudreaux directly beneficially owns 151,020 shares of common stock.
• Additionally, 60 shares are indirectly beneficially owned through a spouse's revocable trust.

Sentiment

Score: 8

Explanation: The significant open market purchase of company stock by the President and CEO indicates strong positive sentiment and confidence in the company's future performance.

Positives

• The President and CEO's open market purchase of 8,500 shares indicates strong confidence in the company's current valuation and future prospects.
• Insider buying, especially by a top executive, often signals a belief that the stock is undervalued or that significant positive developments are anticipated.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Industry Context

This insider purchase by the CEO of a major healthcare company like Elevance Health can be interpreted as a positive signal for the broader health insurance and managed care sector, suggesting executive confidence in the industry's stability and growth prospects.

Related Party Transactions

• The reported transactions are open market purchases of common stock by Gail Boudreaux, the President and CEO of Elevance Health, Inc., which are considered related party transactions due to her executive and director roles.

Stakeholder Impact

• Shareholders may view the CEO's stock purchase as a positive indicator of future performance and management's belief in the company's value, potentially increasing investor confidence.
• Employees may perceive this as a sign of stability and positive outlook for the company.

Key Dates

Recommendation

Keywords

Elevance Health, ELV, Gail Boudreaux, Insider Trading, Stock Purchase, CEO, Director, Beneficial Ownership, Healthcare, Health Insurance